Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 446

2.

Multiparametric MRI for prostate cancer diagnosis: current status and future directions.

Stabile A, Giganti F, Rosenkrantz AB, Taneja SS, Villeirs G, Gill IS, Allen C, Emberton M, Moore CM, Kasivisvanathan V.

Nat Rev Urol. 2019 Jul 17. doi: 10.1038/s41585-019-0212-4. [Epub ahead of print] Review.

PMID:
31316185
3.

Object correspondence: Using perceived causality to infer how the visual system knows what went where.

Moore CM, Stephens T, Hein E.

Atten Percept Psychophys. 2019 Jun 18. doi: 10.3758/s13414-019-01763-y. [Epub ahead of print]

PMID:
31214971
4.

Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.

Kasivisvanathan V, Stabile A, Neves JB, Giganti F, Valerio M, Shanmugabavan Y, Clement KD, Sarkar D, Philippou Y, Thurtle D, Deeks J, Emberton M, Takwoingi Y, Moore CM.

Eur Urol. 2019 May 23. pii: S0302-2838(19)30360-4. doi: 10.1016/j.eururo.2019.04.043. [Epub ahead of print] Review.

PMID:
31130434
5.

The Evolution of MRI of the Prostate: The Past, the Present, and the Future.

Giganti F, Rosenkrantz AB, Villeirs G, Panebianco V, Stabile A, Emberton M, Moore CM.

AJR Am J Roentgenol. 2019 Aug;213(2):384-396. doi: 10.2214/AJR.18.20796. Epub 2019 Apr 30.

PMID:
31039022
6.

VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.

Johnston EW, Bonet-Carne E, Ferizi U, Yvernault B, Pye H, Patel D, Clemente J, Piga W, Heavey S, Sidhu HS, Giganti F, O'Callaghan J, Brizmohun Appayya M, Grey A, Saborowska A, Ourselin S, Hawkes D, Moore CM, Emberton M, Ahmed HU, Whitaker H, Rodriguez-Justo M, Freeman A, Atkinson D, Alexander D, Panagiotaki E, Punwani S.

Radiology. 2019 May;291(2):391-397. doi: 10.1148/radiol.2019181749. Epub 2019 Apr 2.

PMID:
30938627
7.

Development of Technologic Solutions to Address Complex Local Requirements of an International Prostate Cancer Clinical Quality Registry.

Sampurno F, Kannan A, Lucas M, Liman J, Connor SE, Pearman E, Millar JL, Moore CM, Villanti P, James E, Huland H, Litwin MS, Evans SM.

JCO Clin Cancer Inform. 2019 Mar;3:1-11. doi: 10.1200/CCI.18.00114.

8.

Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.

Dieffenbacher S, Nyarangi-Dix J, Giganti F, Bonekamp D, Kesch C, Müller-Wolf MB, Schütz V, Gasch C, Hatiboglu G, Hauffe M, Stenzinger A, Duensing S, Schlemmer HP, Moore CM, Hohenfellner M, Radtke JP.

Eur Urol Focus. 2019 Mar 13. pii: S2405-4569(19)30076-8. doi: 10.1016/j.euf.2019.03.001. [Epub ahead of print]

PMID:
30878348
9.

Magnetic resonance imaging and prostate cancer: Perspectives from the UK, Europe and USA.

Giganti F, Stabile A, Moore CM.

Arch Esp Urol. 2019 Mar;72(2):135-141.

PMID:
30855014
10.

Prostate cancer treated with irreversible electroporation: MRI-based volumetric analysis and oncological outcome.

Giganti F, Stabile A, Giona S, Marenco J, Orczyk C, Moore CM, Allen C, Kirkham A, Emberton M, Punwani S.

Magn Reson Imaging. 2019 May;58:143-147. doi: 10.1016/j.mri.2019.02.003. Epub 2019 Feb 12.

PMID:
30768957
11.

Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer.

Stabile A, Orczyk C, Hosking-Jervis F, Giganti F, Arya M, Hindley RG, Dickinson L, Allen C, Punwani S, Jameson C, Freeman A, McCartan N, Montorsi F, Briganti A, Ahmed HU, Emberton M, Moore CM.

BJU Int. 2019 Feb 12. doi: 10.1111/bju.14710. [Epub ahead of print]

PMID:
30753756
12.

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement.

Merriel SWD, Hetherington L, Seggie A, Castle JT, Cross W, Roobol MJ, Gnanapragasam V, Moore CM; Prostate Cancer UK Expert Reference Group on Active Surveillance.

BJU Int. 2019 Jul;124(1):47-54. doi: 10.1111/bju.14707. Epub 2019 Mar 7.

13.

Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound.

Thompson JE, Sridhar AN, Tan WS, Freeman A, Haider A, Allen C, Moore CM, Orczyk C, Mazzon G, Khetrapal P, Shaw G, Rajan P, Mohammed A, Briggs TP, Nathan S, Kelly JD, Sooriakumaran P.

J Urol. 2019 Jun;201(6):1134-1143. doi: 10.1097/JU.0000000000000135.

PMID:
30730409
14.

Daytime temperature is sensed by phytochrome B in Arabidopsis through a transcriptional activator HEMERA.

Qiu Y, Li M, Kim RJ, Moore CM, Chen M.

Nat Commun. 2019 Jan 11;10(1):140. doi: 10.1038/s41467-018-08059-z.

15.

The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification.

Hamid S, Donaldson IA, Hu Y, Rodell R, Villarini B, Bonmati E, Tranter P, Punwani S, Sidhu HS, Willis S, van der Meulen J, Hawkes D, McCartan N, Potyka I, Williams NR, Brew-Graves C, Freeman A, Moore CM, Barratt D, Emberton M, Ahmed HU.

Eur Urol. 2019 May;75(5):733-740. doi: 10.1016/j.eururo.2018.08.007. Epub 2018 Dec 6.

16.

Observing different model types interspersed with physical practice has no effect on consolidation or motor learning of an elbow flexion-extension task.

Moore CM, Lelievre N, Ste-Marie DM.

Hum Mov Sci. 2019 Feb;63:96-107. doi: 10.1016/j.humov.2018.11.014. Epub 2018 Nov 30.

PMID:
30508690
17.

A picture is worth a thousand words… but does it add utility to a nomogram to predict extraprostatic extension?

Moore CM.

BJU Int. 2018 Dec;122(6):915-916. doi: 10.1111/bju.14478. No abstract available.

PMID:
30460790
18.

Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK.

Bass EJ, Freeman A, Jameson C, Punwani S, Moore CM, Arya M, Emberton M, Ahmed HU.

BMJ Open. 2018 Oct 24;8(10):e024941. doi: 10.1136/bmjopen-2018-024941.

19.

Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program.

Giganti F, Allen C, Piper JW, Mirando D, Stabile A, Punwani S, Kirkham A, Emberton M, Moore CM.

Magn Reson Imaging. 2019 Apr;57:34-39. doi: 10.1016/j.mri.2018.10.013. Epub 2018 Oct 20.

PMID:
30352271
20.

Analysis of Drugs in Oral Fluid Using LC-MS/MS.

Coulter CA, Moore CM.

Methods Mol Biol. 2019;1872:237-259. doi: 10.1007/978-1-4939-8823-5_22.

PMID:
30350295
21.

Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and spectroscopy study.

Deligiannidis KM, Fales CL, Kroll-Desrosiers AR, Shaffer SA, Villamarin V, Tan Y, Hall JE, Frederick BB, Sikoglu EM, Edden RA, Rothschild AJ, Moore CM.

Neuropsychopharmacology. 2019 Feb;44(3):546-554. doi: 10.1038/s41386-018-0242-2. Epub 2018 Oct 17.

PMID:
30327498
22.

Discovery of the actinoplanic acid pathway in Streptomyces rapamycinicus reveals a genetically conserved synergism with rapamycin.

Mrak P, Krastel P, Pivk Lukančič P, Tao J, Pistorius D, Moore CM.

J Biol Chem. 2018 Dec 28;293(52):19982-19995. doi: 10.1074/jbc.RA118.005314. Epub 2018 Oct 16.

23.

A Dedicated Prostate MRI Teaching Course Improves the Ability of the Urologist to Interpret Clinically Significant Prostate Cancer on Multiparametric MRI.

Kasivisvanathan V, Ambrosi A, Giganti F, Chau E, Kirkham A, Punwani S, Allen C, Emberton M, Moore CM.

Eur Urol. 2019 Jan;75(1):203-204. doi: 10.1016/j.eururo.2018.09.033. Epub 2018 Oct 14. No abstract available.

PMID:
30327275
24.

Comparing a Statistical Model and Bayesian Approach to Establish the Design Space for the Coating of Ciprofloxacin HCl Beads at Different Scales of Production.

Kothari BH, Fahmy R, Claycamp HG, Moore CMV, Chatterjee S, Hoag SW.

AAPS PharmSciTech. 2018 Nov;19(8):3809-3828. doi: 10.1208/s12249-018-1116-y. Epub 2018 Oct 2.

PMID:
30280352
25.

Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning.

Simmons LAM, Kanthabalan A, Arya M, Briggs T, Charman SC, Freeman A, Gelister J, Jameson C, McCartan N, Moore CM, van der Muelen J, Emberton M, Ahmed HU.

Prostate Cancer Prostatic Dis. 2019 May;22(2):261-267. doi: 10.1038/s41391-018-0094-1. Epub 2018 Oct 2.

PMID:
30279583
26.

Roadmaps and Detours: Active Chlorophyll- a Assessments of Primary Productivity Across Marine and Freshwater Systems.

Hughes DJ, Campbell DA, Doblin MA, Kromkamp JC, Lawrenz E, Moore CM, Oxborough K, Prášil O, Ralph PJ, Alvarez MF, Suggett DJ.

Environ Sci Technol. 2018 Nov 6;52(21):12039-12054. doi: 10.1021/acs.est.8b03488. Epub 2018 Oct 5.

27.

Structural and functional characterization of IdiA/FutA (Tery_3377), an iron-binding protein from the ocean diazotroph Trichodesmium erythraeum.

Polyviou D, Machelett MM, Hitchcock A, Baylay AJ, MacMillan F, Moore CM, Bibby TS, Tews I.

J Biol Chem. 2018 Nov 23;293(47):18099-18109. doi: 10.1074/jbc.RA118.001929. Epub 2018 Sep 14.

28.

Editorial Comment.

Moore CM.

J Urol. 2018 Nov;200(5):1121. doi: 10.1016/j.juro.2018.06.085. Epub 2018 Aug 17. No abstract available.

PMID:
30121169
29.

MRI in active surveillance: a critical review.

Stavrinides V, Giganti F, Emberton M, Moore CM.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):5-15. doi: 10.1038/s41391-018-0077-2. Epub 2018 Aug 16. Review.

PMID:
30115960
30.

MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years.

Stabile A, Giganti F, Emberton M, Moore CM.

Prostate Cancer Prostatic Dis. 2018 Nov;21(4):473-487. doi: 10.1038/s41391-018-0071-8. Epub 2018 Aug 13. Review.

PMID:
30104656
31.

Handling heme: The mechanisms underlying the movement of heme within and between cells.

Donegan RK, Moore CM, Hanna DA, Reddi AR.

Free Radic Biol Med. 2019 Mar;133:88-100. doi: 10.1016/j.freeradbiomed.2018.08.005. Epub 2018 Aug 6. Review.

PMID:
30092350
32.

MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.

Kasivisvanathan V, Emberton M, Moore CM.

N Engl J Med. 2018 Aug 9;379(6):589-590. doi: 10.1056/NEJMc1807507. No abstract available.

PMID:
30089067
33.

The natural history of prostate cancer on MRI: lessons from an active surveillance cohort.

Giganti F, Moore CM, Punwani S, Allen C, Emberton M, Kirkham A.

Prostate Cancer Prostatic Dis. 2018 Nov;21(4):556-563. doi: 10.1038/s41391-018-0058-5. Epub 2018 Jul 23.

PMID:
30038388
34.

Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial.

Simmons LAM, Kanthabalan A, Arya M, Briggs T, Barratt D, Charman SC, Freeman A, Hawkes D, Hu Y, Jameson C, McCartan N, Moore CM, Punwani S, van der Muelen J, Emberton M, Ahmed HU.

J Urol. 2018 Dec;200(6):1227-1234. doi: 10.1016/j.juro.2018.07.001. Epub 2018 Jul 11.

PMID:
30017964
35.

Weakly-supervised convolutional neural networks for multimodal image registration.

Hu Y, Modat M, Gibson E, Li W, Ghavami N, Bonmati E, Wang G, Bandula S, Moore CM, Emberton M, Ourselin S, Noble JA, Barratt DC, Vercauteren T.

Med Image Anal. 2018 Oct;49:1-13. doi: 10.1016/j.media.2018.07.002. Epub 2018 Jul 4.

36.

Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.

Walter ND, Moore CM, Kayigire XA, Dide-Agossou C, Worodria W, Huang L, Everett CK, Schoolnik GS, Nahid P, Davis JL.

BMC Infect Dis. 2018 Jul 3;18(1):293. doi: 10.1186/s12879-018-3213-7.

37.

A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.

Guillaumier S, Peters M, Arya M, Afzal N, Charman S, Dudderidge T, Hosking-Jervis F, Hindley RG, Lewi H, McCartan N, Moore CM, Nigam R, Ogden C, Persad R, Shah K, van der Meulen J, Virdi J, Winkler M, Emberton M, Ahmed HU.

Eur Urol. 2018 Oct;74(4):422-429. doi: 10.1016/j.eururo.2018.06.006. Epub 2018 Jun 28.

38.

Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches.

Warlick C, Futterer J, Maruf M, George AK, Rastinehad AR, Pinto PA, Bosaily AE, Villers A, Moore CM, Mendhiratta N, Taneja SS, Ukimura O, Konety BR.

World J Urol. 2019 Mar;37(3):419-427. doi: 10.1007/s00345-018-2374-8. Epub 2018 Jun 25. Review.

PMID:
29943220
39.

Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study.

Miah S, Eldred-Evans D, Simmons LAM, Shah TT, Kanthabalan A, Arya M, Winkler M, McCartan N, Freeman A, Punwani S, Moore CM, Emberton M, Ahmed HU.

J Urol. 2018 Dec;200(6):1235-1240. doi: 10.1016/j.juro.2018.06.033. Epub 2018 Jun 27.

40.

"Don't Let the Perfect Be the Enemy of the Good": Time to Embrace Magnetic Resonance Imaging Before First Prostate Biopsy.

Kasivisvanathan V, Emberton M, Moore CM.

Eur Urol. 2018 Oct;74(4):411-412. doi: 10.1016/j.eururo.2018.06.012. Epub 2018 Jun 22. No abstract available.

PMID:
29937197
41.

Geographical CO2 sensitivity of phytoplankton correlates with ocean buffer capacity.

Richier S, Achterberg EP, Humphreys MP, Poulton AJ, Suggett DJ, Tyrrell T, Moore CM.

Glob Chang Biol. 2018 Sep;24(9):4438-4452. doi: 10.1111/gcb.14324. Epub 2018 Jun 21.

PMID:
29799660
42.

CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study.

Lynch DA, Moore CM, Wilson C, Nevrekar D, Jennermann T, Humphries SM, Austin JHM, Grenier PA, Kauczor HU, Han MK, Regan EA, Make BJ, Bowler RP, Beaty TH, Curran-Everett D, Hokanson JE, Curtis JL, Silverman EK, Crapo JD; Genetic Epidemiology of COPD (COPDGene) Investigators.

Radiology. 2018 Sep;288(3):859-866. doi: 10.1148/radiol.2018172294. Epub 2018 May 15.

PMID:
29762095
43.

National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting.

Brizmohun Appayya M, Adshead J, Ahmed HU, Allen C, Bainbridge A, Barrett T, Giganti F, Graham J, Haslam P, Johnston EW, Kastner C, Kirkham APS, Lipton A, McNeill A, Moniz L, Moore CM, Nabi G, Padhani AR, Parker C, Patel A, Pursey J, Richenberg J, Staffurth J, van der Meulen J, Walls D, Punwani S.

BJU Int. 2018 Jul;122(1):13-25. doi: 10.1111/bju.14361. Epub 2018 Jun 5.

44.

Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis.

Schoots IG, Nieboer D, Giganti F, Moore CM, Bangma CH, Roobol MJ.

BJU Int. 2018 Dec;122(6):946-958. doi: 10.1111/bju.14358. Epub 2018 Jun 6.

PMID:
29679430
45.

Neurochemical differences between bipolar disorder type I and II in superior temporal cortices: A proton magnetic resonance spectroscopy study.

Atagün Mİ, Şıkoğlu EM, Can SS, Uğurlu GK, Kaymak SU, Çayköylü A, Algın O, Phillips ML, Moore CM, Öngür D.

J Affect Disord. 2018 Aug 1;235:15-19. doi: 10.1016/j.jad.2018.04.010. Epub 2018 Apr 4.

46.

Magnetic resonance imaging in active surveillance-a modern approach.

Giganti F, Moore CM.

Transl Androl Urol. 2018 Feb;7(1):116-131. doi: 10.21037/tau.2017.12.23. Review.

47.

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM; PRECISION Study Group Collaborators.

N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18.

48.

Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals.

Melnychuk M, Vindrola-Padros C, Aitchison M, Clarke CS, Fulop NJ, Levermore C, Maddineni SB, Moore CM, Mughal MM, Perry C, Pritchard-Jones K, Ramsay AIG, Shackley D, Vickers J, Morris S.

BMC Cancer. 2018 Feb 27;18(1):226. doi: 10.1186/s12885-018-4137-8.

49.

White matter integrity in medication-free women with peripartum depression: a tract-based spatial statistics study.

Silver M, Moore CM, Villamarin V, Jaitly N, Hall JE, Rothschild AJ, Deligiannidis KM.

Neuropsychopharmacology. 2018 Jun;43(7):1573-1580. doi: 10.1038/s41386-018-0023-y. Epub 2018 Feb 5.

50.

Technical Note: Error metrics for estimating the accuracy of needle/instrument placement during transperineal magnetic resonance/ultrasound-guided prostate interventions.

Bonmati E, Hu Y, Villarini B, Rodell R, Martin P, Han L, Donaldson I, Ahmed HU, Moore CM, Emberton M, Barratt DC.

Med Phys. 2018 Apr;45(4):1408-1414. doi: 10.1002/mp.12814. Epub 2018 Mar 9.

Supplemental Content

Loading ...
Support Center